Last updated on June 2012

ANBL0032: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue


Brief description of study

ANBL0032: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue

Detailed Study Description

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT00026312?term=ANBL0032&rank=1

Clinical Study Identifier: TX135885

Contact Investigators or Research Sites near you

Start Over

Patricia Green

Memorial University Medical Center
Savannah, GA USA
  Connect »